Clinical Trial Update: A Clinical Trial of IPT-A to Prevent Suicide in Depressed Adolescents With Suicidal Behavior [Phase 3]

View source ↗

Summary

Phase 3 trial of IPT-A to prevent suicide in depressed adolescents with suicidal behavior has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder
• Persistent Depressive Disorder

Drugs mentioned

• IPT-A (Interpersonal Psychotherapy for Adolescent Suicide Prevention)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Unipolar Depression, Dysthymia | Phase 3 | Status: COMPLETED